Phil Black
Co-Founder @ True Ventures
San Francisco, United States
Phil Black is a seed investor at True Ventures in San Francisco focused on SaaS and Software. Phil is an early stage venture capitalist and co-founder of True Ventures. He learned the venture trade and met his future True Ventures co-founder during his time at Summit Partners. He held general partner positions for eight years prior to raising and investing a small angel fund called Blacksmith Capital, which became a seminal moment in hiscareer of managing venture fund investments. Phil believes in risk-taking at the earliest stage and that startup founders benefit most when they are supported fully, both professionally and personally. Phil is a product of Oklahoma and Stanford alumni. He loves art, wine, and travel. His favorite place outside of the San Francisco Bay Area is London.
- Total investments:
- 37
- Last investment:
- Lead investor:
- 54%
Last updated:
For AI agents: llms.txt
Industries Phil Black invests in
Stages Phil Black invests in
Countries Phil Black invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- SaaS 6 (16%)
- Software 4 (11%)
- Customer Service 4 (11%)
- Financial Services 4 (11%)
- Enterprise Software 4 (11%)
Stage
- Seed 10 (27%)
- Series A 8 (22%)
- Series B 7 (19%)
- Venture - Series Unknown 4 (11%)
- Pre-Seed 1 (3%)
Country
- United States 14 (38%)
- United Kingdom 2 (5%)
- France 1 (3%)
- Singapore 1 (3%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Tenkara makes AI agents that help companies that make things with their back-office work. | $7M / Venture - Series Unknown / Mar 17, 2026 | ||
| Ernesta provides design-focused custom rugs to homes and places of gathering through an enjoyable, frictionless, and affordable experience. | $20M / Series B / Mar 11, 2026 | ||
| Orreco Their mission is to deliver a cutting edge biomarker program to optimise player performance, recovery and welfare. A tailored biomarker program can optimise player health and welfare and use sports science resources to target key or “at risk” players which will lead to increased player availability. Tailoring of recovery and playermanagement strategies to individuals’ own biomarker profiles backs up decision making processes with data giving your team an informed recovery strategy. | $4M / Dec 15, 2025 | ||
| Moneta Moneta Provides brain health digital therapy platform covered by insurance digital therapy to treat and prevent dementia. | $4.5M / Seed / Feb 13, 2025 | ||
| AccessPay develops and offers cloud-based payment and cash management solutions. The company’s cloud-based service provides ease of integration with any ERP, TMS, or other back-end systems. It also enables the straight-through processing of domestic and international payments via BACS, FPS, CHAPS, and SWIFT. By connecting an organization’s backoffice systems with its banks and providing a consolidated view of all banking relationships, AccessPay gives corporate enterprises real-time visibility of all cash balances and offers a detailed analysis, which helps financial professionals maximize the use of working capital. The company was founded in 2012 and is based in London, United Kingdom. | $23.8M / Venture - Series Unknown / Mar 21, 2024 | ||
| Tiamat is a start-up producing affordable animal-free growth factors and biomolecules using plants as bioreactors. Thanks to its propriety platform, the company can manufacture a wide range of high-value proteins from antigens to growth factors.The company has already achieved a 10x cost reduction and at scale can get costs down 1000x even at 80%growth-margins, giving them a wide ability to price strategically. the coming years. The low investment needed to build a facility (up to 40x less than current solutions) combined with its unique technology makes Tiamat the ideal partner in production scale-up for promising markets that will soon become enormous such as cellular agriculture or cell & gene therapy. | $2M / Seed / Mar 09, 2023 | ||
| Moneta Moneta Provides brain health digital therapy platform covered by insurance digital therapy to treat and prevent dementia. | $2.2M / Pre-Seed / Mar 01, 2023 | ||
| Directus is an Open Data Platform for managing the content of any SQL database. It provides a powerful API layer for developers and an intuitive App for non-technical users. Written in JavaScript, Directus is completely open-source, modular, and extensible, allowing it to be fully tailored to your exact project needs. | $7M / Series A / Nov 10, 2022 | ||
| Ernesta provides design-focused custom rugs to homes and places of gathering through an enjoyable, frictionless, and affordable experience. | $25M / Series A / Nov 07, 2022 | ||
| Neoplants use synthetic biology to design plants for the future. | $20M / Seed / Oct 27, 2022 | ||
| See all 37 investments → | |||
Co-Investors
About True Ventures
Founded in 2005, True Ventures is a Silicon Valley-based venture capital firm that invests in early-stage technology startups. With more than $3.8 billion under management, True provides seed and Series A financing to entrepreneurs in some of today's growing markets. With more than 40 team members including special advisors, operationsprofessionals, and founders-turned-investors, True represents one of the largest and most experienced teams dedicated to the ecosystem. The True team believes creativity flourishes when founders are supported fully and empowered to pursue brave ideas. To that end, the True Platform offers programs that inspire professional and personal growth. To date, True has helped more than 350 companies launch and scale their businesses, creating over 85,000 jobs worldwide. True was awarded Venture Firm of the Year by the National Venture Capital Association in 2018. To learn more, visit www.trueventures.com.
True Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Amy Tusman
Executive Assistant
|
|||
Gus Coldebella
Partner
|
|||
Jeffrey Veen
Design Partner and Head of Platform
|
|||
Rohit Sharma
Partner
|
|||
Adam D'Augelli
Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Phil Black invest in?
Phil Black invests primarily in SaaS, Software and Customer Service startups, most often at Seed and Series A stage. Most of the 37 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Phil Black?
Public channels for Phil Black include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Phil Black last invest?
The most recent investment recorded for Phil Black closed in Mar 2026. Shizune tracks 37 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
